ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/15/2025
Back to search
Official data from USPTO
BIOXXMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOXXMED
ST13
US500000079369668Class
5, 35, 36
Filing
79369668
Registration
7416528
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
05/17/2025
Trademark type
Word
Nice classes
5, 35, 36
Filing date
01/12/2023
Registration date
06/18/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/18/2024
Last transaction
05/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
DE
Examiner
BROWNE, LUCY
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
bioXXmed AG
Representatives
Mark P. Stone Law Office of Mark P. Stone
Technical classification
Nice Classes
Class 5Class 35Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of acute and chronic wounds of any origin and other skin diseases; veterinary preparations for treatment of acute and chronic wounds in pets and livestock; sanitary sterilizing preparations; diagnostic agentspreparations and substances for medical purposes; dietetic preparations adapted for medical purposes and food supplements
Class 35
Advertisingmarketing and promotion services; commercial management services and consumer information servicesarranging commercial business contacts for othersbusiness organization consultancycompany valuations in the nature of business appraisals in business matterspublicity agency services related to organizing business launchesnegotiating business contracts for others for the purchase and sale of goodsarranging of buying and selling contracts for others; business assistancemanagement and administrative services; business consultancy and advisory services; interim business management
Class 36
Financial servicesprivate equity fund investment services; financing services for biotechnologymedical technology and pharmaceutical companies; private equity fundraising services and financial evaluation services in the field of biotechnologymedical technologypharaceutical technology
Publications
History of USPTO decisions and trademark events.
30 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/28/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/05/2024
FIMP
FINAL DISPOSITION PROCESSED
12/05/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/18/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/18/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2024
PUBO
PUBLISHED FOR OPPOSITION
04/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/27/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/23/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/23/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/23/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/23/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/16/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/16/2024
RFNP
REFUSAL PROCESSED BY IB
11/13/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/24/2023
RFRR
REFUSAL PROCESSED BY MPU
10/23/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/11/2023
CNRT
NON-FINAL ACTION WRITTEN
10/10/2023
DOCK
ASSIGNED TO EXAMINER
10/10/2023
MAFR
APPLICATION FILING RECEIPT MAILED
05/23/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/19/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/18/2023
Continuous trademark protection
Get notified about every new filing that threatens BIOXXMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.